RETN and esophageal squamous cell carcinoma: Based on these results, we could hypothesize that the decreased resistin level in BBD may be a biochemical marker of metabolic alterations related to the development of BC and other neoplasms such as epithelial ovarian cancer, endometrial cancer, and esophageal squamous cell carcinoma [29,30,31].